Drug Discovery Biology, Monash Institute of Pharmaceutical Science, Monash University, Parkville, Australia (K.L., T.M.J., A.N.K.); Nuffield Department of Women's & Reproductive Health (F.M.H.) and Academic Endocrine Unit, Radcliffe Department of Clinical Medicine (F.M.H., R.V.T.), University of Oxford, Oxford, United Kingdom; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (T.C.M., H.B.-O.); Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom (D.T.W.); Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria (E.K.); Physiology, School of Medical Sciences and Bosch Institute (R.S.M.) and School of Life & Environmental Sciences, Charles Perkins Centre (A.D.C.), University of Sydney, Sydney, Australia; and School of Biosciences, Cardiff University, Cardiff, United Kingdom (D.R.)
Drug Discovery Biology, Monash Institute of Pharmaceutical Science, Monash University, Parkville, Australia (K.L., T.M.J., A.N.K.); Nuffield Department of Women's & Reproductive Health (F.M.H.) and Academic Endocrine Unit, Radcliffe Department of Clinical Medicine (F.M.H., R.V.T.), University of Oxford, Oxford, United Kingdom; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (T.C.M., H.B.-O.); Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom (D.T.W.); Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria (E.K.); Physiology, School of Medical Sciences and Bosch Institute (R.S.M.) and School of Life & Environmental Sciences, Charles Perkins Centre (A.D.C.), University of Sydney, Sydney, Australia; and School of Biosciences, Cardiff University, Cardiff, United Kingdom (D.R.).
Pharmacol Rev. 2020 Jul;72(3):558-604. doi: 10.1124/pr.119.018531.
The calcium-sensing receptor (CaSR) is a class C G protein-coupled receptor that responds to multiple endogenous agonists and allosteric modulators, including divalent and trivalent cations, L-amino acids, -glutamyl peptides, polyamines, polycationic peptides, and protons. The CaSR plays a critical role in extracellular calcium (Ca ) homeostasis, as demonstrated by the many naturally occurring mutations in the CaSR or its signaling partners that cause Ca homeostasis disorders. However, CaSR tissue expression in mammals is broad and includes tissues unrelated to Ca homeostasis, in which it, for example, regulates the secretion of digestive hormones, airway constriction, cardiovascular effects, cellular differentiation, and proliferation. Thus, although the CaSR is targeted clinically by the positive allosteric modulators (PAMs) cinacalcet, evocalcet, and etelcalcetide in hyperparathyroidism, it is also a putative therapeutic target in diabetes, asthma, cardiovascular disease, and cancer. The CaSR is somewhat unique in possessing multiple ligand binding sites, including at least five putative sites for the "orthosteric" agonist Ca , an allosteric site for endogenous L-amino acids, two further allosteric sites for small molecules and the peptide PAM, etelcalcetide, and additional sites for other cations and anions. The CaSR is promiscuous in its G protein-coupling preferences, and signals via G, G, potentially G, and even G in some cell types. Not surprisingly, the CaSR is subject to biased agonism, in which distinct ligands preferentially stimulate a subset of the CaSR's possible signaling responses, to the exclusion of others. The CaSR thus serves as a model receptor to study natural bias and allostery. SIGNIFICANCE STATEMENT: The calcium-sensing receptor (CaSR) is a complex G protein-coupled receptor that possesses multiple orthosteric and allosteric binding sites, is subject to biased signaling via several different G proteins, and has numerous (patho)physiological roles. Understanding the complexities of CaSR structure, function, and biology will aid future drug discovery efforts seeking to target this receptor for a diversity of diseases. This review summarizes what is known to date regarding key structural, pharmacological, and physiological features of the CaSR.
钙敏感受体 (CaSR) 是一种 C 类 G 蛋白偶联受体,可响应多种内源性激动剂和变构调节剂,包括二价和三价阳离子、L-氨基酸、γ-谷氨酰肽、多胺、多阳离子肽和质子。CaSR 在细胞外钙 (Ca2+) 稳态中发挥关键作用,这一点已被 CaSR 或其信号伴侣的许多天然突变所证明,这些突变导致 Ca2+稳态紊乱。然而,哺乳动物中 CaSR 的组织表达广泛,包括与 Ca2+稳态无关的组织,在这些组织中,它例如调节消化激素的分泌、气道收缩、心血管效应、细胞分化和增殖。因此,尽管钙敏感受体 (CaSR) 在甲状旁腺功能亢进症中被阳性变构调节剂 (PAMs) 西那卡塞、依卡路肽和埃他卡肽靶向治疗,但它也是糖尿病、哮喘、心血管疾病和癌症的潜在治疗靶点。CaSR 有点独特,因为它具有多个配体结合位点,包括至少五个用于“变构”激动剂 Ca2+的假定位点、一个用于内源性 L-氨基酸的变构位点、另外两个用于小分子和肽 PAM、埃他卡肽的变构位点以及其他阳离子和阴离子的另外位点。CaSR 在其 G 蛋白偶联偏好上是混杂的,并且通过 G、G、潜在的 G,甚至在某些细胞类型中通过 G 信号传导。毫不奇怪,CaSR 受到偏性激动剂的影响,其中不同的配体优先刺激 CaSR 可能的信号转导反应的一部分,而排除其他反应。因此,CaSR 可作为研究天然偏性和变构的模型受体。 意义陈述:钙敏感受体 (CaSR) 是一种复杂的 G 蛋白偶联受体,具有多个变构和变构结合位点,通过几种不同的 G 蛋白进行偏性信号转导,具有许多(病理)生理作用。了解 CaSR 的结构、功能和生物学复杂性将有助于未来的药物发现工作,这些工作旨在针对多种疾病靶向该受体。 本综述总结了迄今为止关于 CaSR 的关键结构、药理学和生理学特征的已知信息。